Patent · US Active

Hydrophobically tagged janus kinase inhibitors and uses thereof

US9862688B2 · kind B2 · utility

20Cited by
60References
40Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 23, 2015
Grant dateJan 9, 2018
Priority date
Expiry dateApr 23, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides Janus kinase inhibitors, such as compounds of Formula (I) and Formula (II) wherein RY1 and RY2 comprise a tagged hydrophobic moiety RH. The compounds may covalently or non-covalently bind a kinase (e.g., Janus kinase 3 (JAK3)). The hydrophobic moiety RH may signal to the intracellular protein homeostasis machinery to induce degradation of the targeted kinase. Also provided are pharmaceutical compositions, kits, methods, and uses that involve the compounds for reducing the activity of a kinase and/or treating and/or preventing a condition associated with aberrant activity of a kinase (e.g., a proliferative disease, inflammatory disorder, autoimmune disorder, painful condition, and/or viral infection).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.